Intelligent Bio Solutions (INBS) Notes Payables (2022 - 2024)
Intelligent Bio Solutions has reported Notes Payables over the past 3 years, most recently at $368513.0 for Q1 2024.
- Quarterly results put Notes Payables at $368513.0 for Q1 2024, up 9.83% from a year ago — trailing twelve months through Mar 2024 was $368513.0 (up 9.83% YoY), and the annual figure for FY2023 was $353211.0, changed.
- Notes Payables for Q1 2024 was $368513.0 at Intelligent Bio Solutions, down from $370535.0 in the prior quarter.
- Over the last five years, Notes Payables for INBS hit a ceiling of $523703.0 in Q4 2022 and a floor of $335528.0 in Q1 2023.
- Median Notes Payables over the past 3 years was $360862.0 (2023), compared with a mean of $382220.7.
- Biggest five-year swings in Notes Payables: dropped 29.25% in 2023 and later grew 9.83% in 2024.
- Intelligent Bio Solutions' Notes Payables stood at $523703.0 in 2022, then fell by 29.25% to $370535.0 in 2023, then fell by 0.55% to $368513.0 in 2024.
- The last three reported values for Notes Payables were $368513.0 (Q1 2024), $370535.0 (Q4 2023), and $341834.0 (Q3 2023) per Business Quant data.